Chimezie Anyakora, Author at Businessday NG https://businessday.ng/author/chimeziebloompublichealth-com/ Mon, 24 Apr 2023 23:34:16 +0000 en-US hourly 1 188198514 Enhancing quality improvement and capacity building for African pharmaceutical manufacturers https://businessday.ng/columnist/article/enhancing-quality-improvement-and-capacity-building-for-african-pharmaceutical-manufacturers/ https://businessday.ng/columnist/article/enhancing-quality-improvement-and-capacity-building-for-african-pharmaceutical-manufacturers/#respond Mon, 24 Apr 2023 23:34:16 +0000 https://businessday.ng/?p=724460 pharmaceutical manufacturing in Africa

The African continent has approximately 375 drug makers serving over 1.1 billion people. When one compares this figure to 10,500 drug manufacturers in India and 5,000 in China for a population of 1.4 billion each, it becomes quite apparent that there is significantly limited local manufacturing on the African continent. The consequence of this is […]

read more Enhancing quality improvement and capacity building for African pharmaceutical manufacturers

]]>
https://businessday.ng/columnist/article/enhancing-quality-improvement-and-capacity-building-for-african-pharmaceutical-manufacturers/feed/ 0 724460
Good Manufacturing Practices (GMP) and its impact on pharmaceutical quality in Africa https://businessday.ng/columnist/article/good-manufacturing-practices-gmp-and-its-impact-on-pharmaceutical-quality-in-africa/ https://businessday.ng/columnist/article/good-manufacturing-practices-gmp-and-its-impact-on-pharmaceutical-quality-in-africa/#respond Tue, 18 Apr 2023 05:53:11 +0000 https://businessday.ng/?p=722984 pharmaceutical manufacturing

Amongst low- and middle-income countries worldwide, the African region has the highest prevalence of poor-quality medicines with an 18.7% prevalence of substandard and falsified medicines. These challenges have, in part, been attributed to Africa’s poor local manufacturing capacity and weak compliance of local manufacturers with Good Manufacturing Practices (GMP). In Africa, very few local manufacturers […]

read more Good Manufacturing Practices (GMP) and its impact on pharmaceutical quality in Africa

]]>
https://businessday.ng/columnist/article/good-manufacturing-practices-gmp-and-its-impact-on-pharmaceutical-quality-in-africa/feed/ 0 722984
Poor warehousing practices and its impact on medicines quality in Africa https://businessday.ng/columnist/article/poor-warehousing-practices-and-its-impact-on-medicines-quality-in-africa/ https://businessday.ng/columnist/article/poor-warehousing-practices-and-its-impact-on-medicines-quality-in-africa/#respond Mon, 10 Apr 2023 23:57:48 +0000 https://businessday.ng/?p=721122 Medicine

A third of the world’s population – a large proportion being in Africa – cannot access essential medicines which are vital for the delivery of quality health services. Major factors driving this medicine deficiency include poor management practices and unsuitable storage conditions for medicines, as well as poor storage infrastructure. As a result, medicine stock […]

read more Poor warehousing practices and its impact on medicines quality in Africa

]]>
https://businessday.ng/columnist/article/poor-warehousing-practices-and-its-impact-on-medicines-quality-in-africa/feed/ 0 721122
The rising cholera epidemic in Africa: Strategies for mitigation https://businessday.ng/columnist/article/the-rising-cholera-epidemic-in-africa-strategies-for-mitigation/ https://businessday.ng/columnist/article/the-rising-cholera-epidemic-in-africa-strategies-for-mitigation/#respond Mon, 03 Apr 2023 23:43:08 +0000 https://businessday.ng/?p=719821 Cholera

Globally, disease outbreaks have more than tripled since 1980, with 1307 epidemic events between 2011 and 2017. Cholera was the biggest contributor to this, with 308 events. Since mid-2021, the global situation has further deteriorated with an acute upsurge of cholera cases, which has put one billion people in 43 countries at risk, according to […]

read more The rising cholera epidemic in Africa: Strategies for mitigation

]]>
https://businessday.ng/columnist/article/the-rising-cholera-epidemic-in-africa-strategies-for-mitigation/feed/ 0 719821
Strategies for capacity building of Africa’s analytical and diagnostic laboratories https://businessday.ng/columnist/article/strategies-for-capacity-building-of-africas-analytical-and-diagnostic-laboratories/ https://businessday.ng/columnist/article/strategies-for-capacity-building-of-africas-analytical-and-diagnostic-laboratories/#respond Tue, 28 Mar 2023 04:52:45 +0000 https://businessday.ng/?p=718085 diagnostics system in Africa

Laboratory is one of the core capacities that Africa must develop to achieve resilient health systems. Laboratory services play a major role in all the key processes of detection, assessment, response, notification, and monitoring of public health events. Yet, for a long time, laboratory services were not considered a priority for most resource-limited healthcare systems […]

read more Strategies for capacity building of Africa’s analytical and diagnostic laboratories

]]>
https://businessday.ng/columnist/article/strategies-for-capacity-building-of-africas-analytical-and-diagnostic-laboratories/feed/ 0 718085